Scholarlink

<p>Monoclonal antibody <i>N</i>-glycosylation is a critical quality attribute influencing therapeutic safety and efficacy, and is strongly influenced by bioprocess design. NISTCHO, a publicly available Chinese hamster ovary producer cell line, is increasingly encouraged for use as a reference system. However, the impact of feeding strategies on cellular performance and <i>N</i>-glycosylation has not been assessed. Here, we applied multivariate analysis of compositional <i>N</i>-glycan data to assess how feeding strategies influence <i>N</i>-glycan composition of cNISTmAb. We varied feeding strategies in frequency, glucose supply, and galactose/manganese supplementation. Feeding frequency had minimal impact on quality attributes but strongly affected culture performance, with every-other-day feeding improving titers and cell-specific productivity. High glucose availability supported growth and productivity. Low glucose strategies reduced titers and shifted <i>N</i>-glycosylation towards non-galactosylated and fucosylated species, despite lactate accumulation remaining within favorable ranges. Galactose and manganese consistently increased antibody galactosylation, with galactose additionally serving as an auxiliary carbon source, extending cell viability. Importantly, mAb glycation remained stable across all feeding strategies at harvest. Overall, these results demonstrate that feed composition and timing can be used to tune both cellular performance and mAb glycosylation, establishing NISTCHO as a robust benchmark for standardized process-quality studies.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of feeding strategies on culture performance and product quality in NISTCHO

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月19日

查看全文
  • Veronika Schäpertöns,
  • Larissa Hofer,
  • Thomas Berger,
  • Jerneja Štor,
  • Nicolas Marx,
  • Wolfgang Esser-Skala,
  • Thomas Rauter,
  • Dominik Hofreither,
  • Laura Liesinger,
  • Peter Filzmoser,
  • Ruth Birner-Gruenberger,
  • Christian G. Huber,
  • Nicole Borth,
  • Nikolaus Fortelny

摘要

Monoclonal antibody N-glycosylation is a critical quality attribute influencing therapeutic safety and efficacy, and is strongly influenced by bioprocess design. NISTCHO, a publicly available Chinese hamster ovary producer cell line, is increasingly encouraged for use as a reference system. However, the impact of feeding strategies on cellular performance and N-glycosylation has not been assessed. Here, we applied multivariate analysis of compositional N-glycan data to assess how feeding strategies influence N-glycan composition of cNISTmAb. We varied feeding strategies in frequency, glucose supply, and galactose/manganese supplementation. Feeding frequency had minimal impact on quality attributes but strongly affected culture performance, with every-other-day feeding improving titers and cell-specific productivity. High glucose availability supported growth and productivity. Low glucose strategies reduced titers and shifted N-glycosylation towards non-galactosylated and fucosylated species, despite lactate accumulation remaining within favorable ranges. Galactose and manganese consistently increased antibody galactosylation, with galactose additionally serving as an auxiliary carbon source, extending cell viability. Importantly, mAb glycation remained stable across all feeding strategies at harvest. Overall, these results demonstrate that feed composition and timing can be used to tune both cellular performance and mAb glycosylation, establishing NISTCHO as a robust benchmark for standardized process-quality studies.